I have previously asked JC regarding info into the vax trial and if gender plays a factor in how often an outbreak may occur, driven by menstruation cycles etc. I had also asked about additional boosters and if we were to 'tweak' future trials. The short answer was they had been working with new alternative intra-dermal delivery devices. I would like further clarification of what these may be..
- Forums
- ASX - By Stock
- Questions for AGM?
I have previously asked JC regarding info into the vax trial and...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.32 |
Change
-0.590(5.95%) |
Mkt cap ! $196.8M |
Open | High | Low | Value | Volume |
$9.50 | $9.61 | $9.30 | $129.4K | 13.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 497 | $9.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.87 | 1400 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1010 | 9.310 |
1 | 1915 | 9.300 |
2 | 1044 | 9.250 |
2 | 412 | 9.200 |
1 | 1000 | 9.000 |
Price($) | Vol. | No. |
---|---|---|
9.870 | 1347 | 4 |
9.880 | 459 | 2 |
9.890 | 218 | 1 |
9.910 | 13 | 1 |
10.000 | 10250 | 2 |
Last trade - 14.37pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online